Practice
Featured experience
MSG Networks comprehensive out-of-court debt restructuring
We advised the administrative agent and a lender on the transaction
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Grayscale CoinDesk Crypto 5 ETF approved as first U.S. multi-asset crypto ETF
We advised Grayscale on securing SEC approval for the NYSE Arca listing
Applied Materials $1 billion senior notes offering
The investment-grade notes are due 2031 and 2036
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Oscar Health $410 million convertible senior subordinated notes and capped call transactions
The 2.25% convertible notes are due 2030
Norwegian Cruise Line Holdings comprehensive refinancing transactions
The transactions included new debt, exchangeable debt, registered direct equity offerings and concurrent tender offers
Bombardier $250 million senior notes offering
The investment-grade senior notes are due 2033
Natura sale of Avon International to Regent
We are advising Natura on the sale
Century Communities $500 million senior notes offering and concurrent redemption
The high-yield notes are due 2033
GrowthCurve Capital acquisition of PlanHub
We advised GrowthCurve Capital on the transaction
Royalty Pharma $2 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering